Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Mettmann

11 clinical trials in Mettmann, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Mettmann at a glance
11
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

11 trials in Mettmann

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Durvalumab
  • Sponsor:AstraZeneca AB
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Tenecteplase
  • Sponsor:University Medical Center Hamburg-Eppendorf
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Lauromacrogol 400
  • Sponsor:Engene Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Enzalutamide
  • Sponsor:Pfizer Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Durvalumab
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Pfizer Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cetrelimab
  • Sponsor:Janssen - Cilag International
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Mitomycin
  • Sponsor:Janssen - Cilag International
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cetrelimab
  • Sponsor:Janssen - Cilag International
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:AstraZeneca AB

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Mettmann

What the registry says about research in the country

01 Bladder Cancer Research

Innovative trials focusing on non-muscle invasive bladder cancer treatments, combining established therapies with new approaches.

  • BCG Combination Studies
  • Novel Therapeutic Combinations
  • High-Risk NMIBC Management

Research emphasis on improving disease-free survival rates through combination therapies and immunological approaches.

02 Prostate Cancer Interventions

Comprehensive studies targeting metastatic prostate cancer with various stages and presentations.

  • Hormone-Sensitive Treatment Approaches
  • Castration-Resistant Protocols
  • Combination Therapy Evaluation

Focus on developing targeted treatments and assessing progression-free survival outcomes.

03 Advanced Cancer Therapeutics

Investigation of novel drug combinations and treatment protocols for urological cancers.

  • Targeted Molecular Therapies
  • Immunotherapy Applications
  • Personalized Treatment Approaches

Emphasis on innovative therapeutic strategies and personalized medicine approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.